🇺🇸 FDA
Patent

US 9241976

Use of HDL-related molecules to treat and prevent proinflammatory conditions

granted A61KA61K38/00A61K38/16

Quick answer

US patent 9241976 (Use of HDL-related molecules to treat and prevent proinflammatory conditions) held by The Regents of the University of California expires Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 26 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 21 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K38/00, A61K38/16, A61K38/1709, A61P